Clinical Feature: Dyslipidemia & Antipsychotic Medications: Who is Monitoring the Lipids? | National Lipid Association Online
![Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis - The Lancet Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis - The Lancet](https://www.thelancet.com/cms/attachment/ea0363eb-f399-4d24-b4fb-bfe4cb140431/gr1_lrg.jpg)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis - The Lancet
![Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia | BJPsych Advances | Cambridge Core Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia | BJPsych Advances | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20191211165252554-0686:S2056467819000495:S2056467819000495_fig2g.jpeg?pub-status=live)
Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia | BJPsych Advances | Cambridge Core
![Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance | Psychiatrist.com Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/v77n1220T5.gif)
Antipsychotic Drugs in Schizophrenia: Relative Effects in Patients With and Without Treatment Resistance | Psychiatrist.com
![Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study - The Lancet Psychiatry Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/ea1ef51b-21f9-429d-b1ab-d42a5924a5dc/gr1.gif)
Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study - The Lancet Psychiatry
![Antipsychotic Drugs Market Share Growing Rapidly 2020 Global Analysis, Size, Trends, Revenue, Statistics, Business Insights, Leading Players, Competitive Landscape with Regional Forecast To 2026 | Medgadget Antipsychotic Drugs Market Share Growing Rapidly 2020 Global Analysis, Size, Trends, Revenue, Statistics, Business Insights, Leading Players, Competitive Landscape with Regional Forecast To 2026 | Medgadget](https://www.medgadget.com/wp-content/uploads/2020/02/ANTIPSYCHOTIC-DRUGS-MARKET.png)